Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: An ink tube according to an embodiment includes a flexible tube body through which an ink flows, and a liquid repellent membrane which coats at least an inner surface of the flexible tube body. The liquid repellent membrane comprising a fluorine compound having a binding moiety containing a silicon atom and a carbon atom and a perfluoroalkyl group of four or fewer carbon atoms. The binding moiety is covalently bonded directly to the inner surface of the flexible tube body, and the perfluoroalkyl group is at a terminal end of the fluorine compound opposite from an end of the binding moiety.

Abstract: The present invention relates to substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: A liquid repellent cloth or liquid repellent film according to an embodiment includes abase fabric selected from a fiber cloth or a synthetic resin film, and a liquid repellent membrane supported on at least one principal face of the base fabric. The liquid repellent membrane is a monomolecular membrane of a fluorine-containing organic compound that binds to a surface of the base fabric through a binding moiety represented by —Z—O—* (wherein Z represents an atomic group containing a Si atom, and * represents a binding site to the surface of the base fabric) and includes a perfluoroalkyl group having 4 or less carbon atoms at a terminal, and the fluorine-containing organic compound undergoes intermolecular bonding between the fluorine-containing organic compounds adjacent to each other by mutual binding of Z in the formula.

Abstract: An ink tube according to an embodiment includes a flexible tube body through which an ink flows, and a liquid repellent membrane which coats at least an inner surface of the flexible tube body. The liquid repellent membrane comprising a fluorine compound having a binding moiety containing a silicon atom and a carbon atom and a perfluoroalkyl group of four or fewer carbon atoms. The binding moiety is covalently bonded directly to the inner surface of the flexible tube body, and the perfluoroalkyl group is at a terminal end of the fluorine compound opposite from an end of the binding moiety.

Abstract: A liquid repellent laminate according to an embodiment includes a transparent substrate having a first principal face and a second principal face as a rear face of the first principal face, and a liquid repellent membrane supported on the first principal face of the transparent substrate. The liquid repellent membrane is a monomolecular membrane of a fluorine-containing organic compound that binds to a surface of the transparent substrate through a binding moiety represented by —Z—O—* (wherein Z represents an atomic group containing a Si atom, and * represents a binding site to the surface of the transparent substrate) and includes a perfluoroalkyl group having 4 or less carbon atoms at a terminal, and the fluorine-containing organic compound undergoes intermolecular bonding between the fluorine-containing organic compounds adjacent to each other by mutual binding of Z in the formula.

Abstract: The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: An ink jet head includes a nozzle plate base including a plurality of nozzles. A liquid repellent film is formed on a surface of the nozzle plate base. The liquid repellent film comprises a polymeric compound formed of repeating units with a cyclic structure. A portion of the repeating units with the cyclic structure are ring-opened.

Abstract: The present invention relates to substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Abstract: According to one embodiment, an inkjet head achieving excellent landing accuracy and an inkjet printer including such an inkjet head are provided. An inkjet head according to one embodiment includes a nozzle plate provided with a nozzle that ejects an ink having a surface tension within a range of 20 to 30 mN/m to a recording medium. The nozzle plate includes a nozzle plate substrate and a fluid repellent film provided on a face opposed to the recording medium of the nozzle plate substrate, and the fluid repellent film contains a fluorine-based compound having a terminal perfluoroalkyl group with 7 or less carbon atoms, and has a static contact angle with pure water within a range of 100° to 120°.

Abstract: An ink jet head includes a nozzle plate substrate having a nozzle for ejecting ink toward a recording medium and an oil repellent film on a surface of the nozzle plate substrate, the surface facing the recording medium. The oil repellent film includes a fluorine compound having a first end and a second end, the first end having a bonding group bonded to the nozzle plate substrate, the second end having a perfluoroalkyl group, and the bonding group being bonded to a bonding group of an adjacent fluorine compound bonded to the nozzle plate substrate.

Abstract: An ink jet head includes a nozzle plate substrate having a nozzle for ejecting ink toward a recording medium and an oil repellent film on a surface of the nozzle plate, the surface facing the recording medium. The oil repellent film comprises a terminal perfluoroalkyl group including a CF2 group, a CF3 group, and a CF3+? group.

Abstract: An ink jet head includes a nozzle plate base including a plurality of nozzles. A liquid repellent film is formed on a surface of the nozzle plate base. The liquid repellent film comprises a polymeric compound formed of repeating units with a cyclic structure. A portion of the repeating units with the cyclic structure are ring-opened.